SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-026580
Filing Date
2017-04-11
Accepted
2017-04-11 16:56:08
Documents
2
Period of Report
2017-04-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2168
2 POA DOCUMENT poa.txt EX-24.3_717949 3749
  Complete submission text file 0001209191-17-026580.txt   7390
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Issuer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FRAZIER HEALTHCARE PARTNERS 601 UNION ST., SUITE 3200 SEATTLE WA 98101
Business Address
ESTES DANIEL (Reporting) CIK: 0001702527 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37490 | Film No.: 17756447